AZD0292
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AZD0292, covering 2025-02-27 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization [Phase 2]